Proposed Data Collections Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[INFO-98-24]

Proposed Data Collections Submitted for Public Comment and

Recommendations

In compliance with the requirement of section 3506(c) (2) (A) of

the Paperwork Reduction Act of 1995 for opportunity for public comment

on proposed data collection projects, the Centers for Disease Control

and Prevention (CDC) will publish periodic summaries of proposed

projects. To request more information on the proposed projects or to

obtain a copy of the data collection plans and instruments, call the

CDC Reports Clearance Officer at (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of

information is necessary for the proper performance of the functions of

the agency, including whether the information shall have practical

utility; (b) the accuracy of the

[[Page 41573]]

agency's estimate of the burden of the proposed collection of

information; (c) ways to enhance the quality, utility, and clarity of

the information to be collected; and (d) ways to minimize the burden of

the collection of information on respondents, including through the use

of automated collection techniques or other forms of information

technology. Send comments to Seleda Perryman, CDC Assistant Reports

Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333.

Written comments should be received within 60 days of this notice.

Comments regarding this information collection are best assured of

having their full effect if received within 60 days of the date of this

publication.

Proposed Projects

1. Requirement for a Special Permit to Import Cynomolgus-African

Green or Rhesus Monkeys--(0920-0263)--Extension--National Center for

Infectious Disease (NCID) Division of Quarantine--A registered importer

nonhuman primates must submit to the Director, CDC, a written plan

which specifies the steps that will be taken to prevent exposure of

persons and animals during the entire importation and quarantine

process for the arriving nonhuman primates. Under the special permit

arrangement, registered importers must submit a plan to CDC for the

importation and quarantine if they wish to import the specific monkeys

covered. The plan must address disease prevention procedures to be

carried out in every step of the chain of custody of such monkeys, from

embarkation in the country of origin to release from quarantine.

Information such as species, origin and intended use for monkeys,

transit information, isolation and quarantine procedures, and

procedures for testing of quarantined animals is necessary for CDC to

make public health decisions. This information enables CDC to evaluate

compliance with the standards and determine whether the measures being

taken to prevent exposure of persons and animals during importation are

adequate. Once CDC is assured, through the monitoring of shipments

(normally no more than 2), that the provisions of a special permit plan

are being followed by a new permit holder, and that the use of adequate

disease control practices is being demonstrated, the special permit is

extended to cover the receipt of additional shipments under the same

plan for a period of 180 days, and may be renewed upon request. This

eliminates the burden on importers to repeatedly report identical

information, requiring only that specific shipment itineraries and

information on changes to the plan which require approval be submitted.

The respondents are commercial or not-for-profit importers of

nonhuman primates. We are requesting clearance for 3 years. Total cost

to Respondents: $350 (14 x $25)

----------------------------------------------------------------------------------------------------------------

Number of Avg. burden/

Respondents Number of responses/ responses (in Total burden

respondents respondents hrs.) (in hrs.)

----------------------------------------------------------------------------------------------------------------

Businesses...................................... 5 5 [email protected]; [email protected] 6.5

Organizations................................... 15 5 0.1 7.5

---------------------------------------------------------------

Total..................................... .............. .............. .............. 14

----------------------------------------------------------------------------------------------------------------

Dated: July 29, 1998.

Charles W. Gollmar,

Acting Associate Director for Policy, Planning and Evaluation Centers

for Disease Control and Prevention (CDC).

[FR Doc. 98-20719 Filed 8-3-98; 8:45 am]

BILLING CODE 4163-18-P